CIS-diamminedichloroplatinum(II) inhibits p34cdc2 protein kinase in human lung-cancer cells
β Scribed by Kazuto Nishio; Yasuhiro Fujiwara; Yuki Miyahara; Yuichiro Takeda; Tatsuo Ohira; Naohiro Kubota; Sei Ohta; Yasunori Funayama; Hayato Ogasawara; Nagahiro Saijo; Masahiro Ohata
- Book ID
- 102864389
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 914 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
cis-Diamminedichloroplatinum(ll) (CDDP) induced G2-phase arrest in PC-9 human cancer cells. To elucidate how CDDP acts on cell-cycle regulation, we analyzed the effect of CDDP on cell-cycle regulators such as protein kinase. p34cdc2 protein kinase activity was maximum in G2 phase and decreased after G2/M transition in synchronized PC-9 human lung cancer cells. Evidence for a phosphorylated protein kinase complexed with cyclin B was obtained from cells in G2 phase and the p34cdc2 protein kinase appeared to be dephosphorylated at M phase. After exposure to CDDP in GI phase, PC-9 cells were arrested in G2 phase. The activation of p34cdc2 protein kinase was inhibited by CDDP. Cyclin A and wee-I kinase were not affected by the exposure to CDDP. Cyclin B was degraded in M phase in PC-9 cells. Exposure to CDDP did not affect the degradation of cyclin B. Our data suggest that the effect of
π SIMILAR VOLUMES